The authors studied effects of short-term (8 weeks) combined lipid-lowering and antihypertensive therapy effects on hemostatic parameters in metabolic syndrome (MS) patients.
L. A. Ratnikova +4 more
doaj
Looking Beyond Severe Hypertriglyceridemia when Diagnosing Adult-Onset Citrullinemia Type II. [PDF]
Truong TH +6 more
europepmc +1 more source
Are lipid-lowering therapies used according to the guidelines?: A real-world retrospective study of 1001 patients with type 2 diabetes. [PDF]
Şahin MF, Erol A, Bayrak G, Şahin A.
europepmc +1 more source
Long-term safety and efficacy of oral bezafibrate use in dogs with hypertriglyceridemia. [PDF]
Castonguay-Poirier M +3 more
europepmc +1 more source
Trends in utilization and cost of triglyceride-lowering therapies among Medicare beneficiaries: An analysis from the Medicare part D database. [PDF]
Malkani K +10 more
europepmc +1 more source
Long-Term Adherence and Drug Utilisation Patterns Among New Users of Anti-Hyperlipidemic Monotherapy: Development of a Risk Prediction Model. [PDF]
Li X +4 more
europepmc +1 more source
Second-line therapies in PBC-related cirrhosis: balancing efficacy and safety. [PDF]
Rogalski P, Rogalska M.
europepmc +1 more source
High biochemical remission rates in patients with primary biliary cholangitis treated with "triple" anticholestatic therapy. [PDF]
Cançado GGL +7 more
europepmc +1 more source
Hypertriglyceridaemia-Associated Acute Pancreatitis: Risk Stratification, Drivers, and Prevention of Recurrence. [PDF]
Fogacci F, Cicero AFG.
europepmc +1 more source

